By Sriparna Roy and Abigail Summerville (Reuters) -Band-Aid and Tylenol maker Kenvue has fired its CEO Thibaut Mongon, the consumer health company said on Monday, laying what some investors expect will be the groundwork for an eventual sale of the entire company or pieces of it.

Kenvue’s board of directors are considering ‘a broad range of potential alternatives’ and are hunting for a permanent replacement for CEO Thibaut Mongon

Two years ago, when Johnson & Johnson announced it was spinning off its consumer brands including Tylenol, Band-Aid, Motrin, Sudafed, and Neutrogena into a new company called Kenvue, investor anticipation was high.